These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10083066)
1. Administration of exogenous interleukin-2 enhances obliterative airway disease in cyclosporine-treated rats following tracheal allografts. Takao M; Gu Y; Shimamoto A; Adachi K; Namikawa S; Yada I Transplant Proc; 1999; 31(1-2):180-1. PubMed ID: 10083066 [No Abstract] [Full Text] [Related]
2. Tracheal allograft transplantation in rats: the role of immunosuppressive agents in development of obliterative airway disease. Yonan NA; Bishop P; el-Gamel A; Hutchinson IV Transplant Proc; 1998 Aug; 30(5):2207-9. PubMed ID: 9723443 [No Abstract] [Full Text] [Related]
3. The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model. Gu Y; Takao M; Kai M; Lu L; Shimamoto A; Onoda K; Shimono T; Tanaka K; Shimpo H; Shiraishi T; Yada I Ann Thorac Cardiovasc Surg; 2000 Aug; 6(4):224-31. PubMed ID: 11042477 [TBL] [Abstract][Full Text] [Related]
4. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents. Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton TR; Shorthouse R; Huang X; Reitz BA; Morris RE Transplantation; 1997 Aug; 64(3):373-83. PubMed ID: 9275099 [TBL] [Abstract][Full Text] [Related]
5. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Boehler A; Chamberlain D; Kesten S; Slutsky AS; Liu M; Keshavjee S Transplantation; 1997 Jul; 64(2):311-7. PubMed ID: 9256193 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of airway obliteration by ciprofloxacin in experimental posttransplant bronchiolitis obliterans. Remund K; Rechsteiner T; Rentsch K; Vogt P; Russi EW; Boehler A Transplantation; 2008 Mar; 85(5):726-31. PubMed ID: 18337667 [TBL] [Abstract][Full Text] [Related]
7. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily]. Qi Z; Yang DY; Wang R; Wang SZ; Ping YM Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus. Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562 [TBL] [Abstract][Full Text] [Related]
9. Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts. Yagyu K; van Breda Vriesman PJ; Duijvestijn AM; Bruggeman CA; Steinhoff G Transplant Proc; 1993 Feb; 25(1 Pt 2):1152-4. PubMed ID: 8382853 [No Abstract] [Full Text] [Related]
10. Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats. Ikonen TS; Brazelton TR; Berry GJ; Shorthouse RS; Morris RE Transplantation; 2000 Sep; 70(6):857-63. PubMed ID: 11014638 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease. Lemaître PH; Vokaer B; Charbonnier LM; Iwakura Y; Field KA; Estenne M; Goldman M; Leo O; Remmelink M; Le Moine A Am J Transplant; 2013 Mar; 13(3):611-20. PubMed ID: 23331973 [TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts. Ropponen JO; Syrjälä SO; Krebs R; Nykänen A; Tikkanen JM; Lemström KB J Heart Lung Transplant; 2011 Jun; 30(6):707-16. PubMed ID: 21411341 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection accelerates experimental obliterative bronchiolitis via platelet-derived growth factor upregulation. Koskinen P; Kallio E; Tikkanen J; Bruggeman C; Häyry P; Lemström K Transplant Proc; 1997; 29(1-2):798. PubMed ID: 9123530 [No Abstract] [Full Text] [Related]
14. No gender difference in development of obliterative airway disease in rat tracheal allografts. Antus B; Fillinger J; Sebe A; Jeney C; Soltesz I; Horvath I Exp Mol Pathol; 2006 Dec; 81(3):235-8. PubMed ID: 16859678 [TBL] [Abstract][Full Text] [Related]
15. Recipient cells form the proliferative lesion in the rat heterotopic tracheal allograft model of obliterative airway disease. Jordan JL; Hurley CL; Lee TD; Hirsch GM J Heart Lung Transplant; 2003 Mar; 22(3):357-60. PubMed ID: 12633704 [TBL] [Abstract][Full Text] [Related]
16. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation. Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756 [TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts. Roth-Eichhorn S; Schade I; Kasper M; Ploetze K; Wunderlich J; Funk RH; Schueler S J Heart Lung Transplant; 2001 Nov; 20(11):1188-98. PubMed ID: 11704479 [TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparins do not modify obliterative airway disease in rat tracheal allografts. Fillinger J; Antus B Exp Lung Res; 2010 Dec; 36(10):625-31. PubMed ID: 20860540 [TBL] [Abstract][Full Text] [Related]
19. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas. Qu N; de Vos P; Schelfhorst M; de Haan A; Timens W; Prop J J Heart Lung Transplant; 2005 Jul; 24(7):882-90. PubMed ID: 15982618 [TBL] [Abstract][Full Text] [Related]
20. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Koskinen PK; Kallio EA; Krebs R; Lemström KB Am J Respir Crit Care Med; 1997 Jan; 155(1):303-12. PubMed ID: 9001329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]